NCT06042790|Unknown
Loading search results
Sponsor study identifier
observational
2,500
1 country
1
Study Start
March 1, 2020
Actual (reported)Primary Completion
August 8, 2022
Actual (reported)Study Completion
October 8, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Covid-19 is a disease where both clinical experience and thus knowledge about the long-term effects of the disease are currently sparse. However, current follow-up results indicate a more pronounced cognitive and respiratory impairment than previously seen in a normal ICU population. As we know that the prevalence of impairments in neurocognitive and Health Related Quality of Life (HRQoL) is increased in a majority of ICU patients, it would be of benefit to gain knowledge about the impact on the recovery trajectory for patients treated for Covid-19, and to increase the understanding of which factors that affect the HRQoL and recovery and in what way these differs between patients treated in ICU for Covid-19 and other causes respectively. This can contribute to better structures for follow-up and possibility to individualisation that better address which patients are in risk for decreased HRQoL and where benefit for the patient, health care and social economic can be achieved.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 8, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 1, 2020
Actual (reported)August 8, 2022
Actual (reported)September 12, 2023
Actual (reported)September 21, 2023
Actual (reported)October 8, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
HRQoL
RAND-36
2, 6, 12 months post ICU
Patients with confirmed Covid-19 admitted to ICU care
Non Coivd-19 patients admitted to ICU before 2020
Group I ICU patients with Covid-19 Group II ICU patients without Covid-19
Contact the study team to confirm eligibility.
The Swedish Intensive Care Registry
Karlstad, Sweden
Sten Walther, PhD
Linkoeping University
First Submitted
September 12, 2023
First Posted
September 21, 2023
Study Start
March 1, 2020
Actual (reported)Primary Completion
August 8, 2022
Actual (reported)Feasibility, Acceptability, and Barriers to Implementation of a Geriatrics Bundle in the ICU
Study Completion
October 8, 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
September 21, 2023
Record last verified: 2023-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: